Annual Report FY 2004 - Research at Cornell
01. Tetragenetics, Inc., Brings IchVax Vaccine to Market
In recent years, the laboratory of Theodore G. Clark, Microbiology and Immunology, began exploring biotechnological applications of Tetrahymena thermophilia to over-express therapeutic proteins that are valuable for human and animal health.
02. Health Sciences Group, Inc., Licenses Cornell’s Apple Peel Powder
Apple peels are a discarded waste product of processed apple products, typically dumped in landfills or reprocessed and sold as livestock feed or fertilizer.
03. Transferring Technology, FY 2004

› Top


If you can see this message in a graphical web browser, then you are most likely using a non-modern browser. People who are using a graphical browser have the following options:

Upgrade to a modern generation web browser such as Mozilla, Opera, or for Mac users there is also Safari.

For people using early generation web browsers, such as Netscape 4, you can access the content of this page as is but there may be presentational errors.

Cornell University  
222 Day Hall
Ithaca, New York

P: 607.255.7200
F: 607.255.9030
E: VP Research
C: Credits